glp-1 drug tirzepatide oral glp 1 Eli Lilly to seek approval of new weight-loss this year FDA says shortage of GLP-1 – Concerns Surrounding Compounded GLP-1s Mount

Novartis has filed no meaningful conversion or product-hopping strategy for Entresto, making it a clean cliff rather than a managed LOE event

Reviewed by Dr Mitra Dutt Wegovy is a medicine that helps people with a high body mass index (BMI) lose weight

Identifying Candidates for Weight Loss Medication Adults in Port Richey with a BMI of 30 or more, or those with a BMI of 27 plus conditions like high blood pressure or sleep apnea, are likely candidates

These drugs can be life-changing for patients with diabetes and obesity, helping patients to live healthier lives

Haseeb M et al

Tirzepatide may increase the risk of gallbladder disease (cholelithiasis, cholecystitis)